Inhibition of pi3k class ia kinases using gdc-0941 overcomes cytoprotection of multiple myeloma cells in the osteoclastic bone marrow microenvironment enhancing the efficacy of current clinical therapeutics

HIGHLIGHTS

• who: Hugh Kikuchi and colleagues from the Department of Haemato-Oncology, King`s College London, London , NU, UK Royal Berkshire Hospital, Oxford University Hospitals, Oxford , LE, UK have published the paper: Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics, in the Journal: Cancers 2023, x of /2023/
• what: The authors propose a sequence of analysis based on the high throughput platform for the rapid screening of possible compounds effective for targeting the cytoprotection mediated by . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.